SeaSpine Holdings Corporation (SPNE): Price and Financial Metrics


SeaSpine Holdings Corporation (SPNE): $16.23

0.48 (+3.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SPNE POWR Grades


  • Sentiment is the dimension where SPNE ranks best; there it ranks ahead of 88.33% of US stocks.
  • The strongest trend for SPNE is in Momentum, which has been heading down over the past 48 weeks.
  • SPNE ranks lowest in Quality; there it ranks in the 8th percentile.

SPNE Stock Summary

  • For SPNE, its debt to operating expenses ratio is greater than that reported by merely 9.59% of US equities we're observing.
  • SPNE's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 14.47% of US stocks.
  • With a year-over-year growth in debt of -49.04%, SeaSpine Holdings Corp's debt growth rate surpasses only 9.69% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to SeaSpine Holdings Corp, a group of peers worth examining would be PMD, CXDO, XGN, LNN, and HAE.
  • SPNE's SEC filings can be seen here. And to visit SeaSpine Holdings Corp's official web site, go to www.seaspine.com.

SPNE Valuation Summary

  • SPNE's price/sales ratio is 3.4; this is 70.04% lower than that of the median Healthcare stock.
  • SPNE's price/sales ratio has moved up 1.8 over the prior 76 months.
  • Over the past 76 months, SPNE's price/sales ratio has gone up 1.8.

Below are key valuation metrics over time for SPNE.

Stock Date P/S P/B P/E EV/EBIT
SPNE 2021-08-31 3.4 1.8 -17.5 -14.4
SPNE 2021-08-30 3.3 1.8 -17.0 -13.9
SPNE 2021-08-27 3.3 1.8 -17.1 -14.0
SPNE 2021-08-26 3.2 1.7 -16.6 -13.5
SPNE 2021-08-25 3.2 1.7 -16.6 -13.5
SPNE 2021-08-24 3.2 1.7 -16.3 -13.2

SPNE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SPNE has a Quality Grade of D, ranking ahead of 8.75% of graded US stocks.
  • SPNE's asset turnover comes in at 0.673 -- ranking 56th of 183 Medical Equipment stocks.
  • KRMD, IRMD, and NUVA are the stocks whose asset turnover ratios are most correlated with SPNE.

The table below shows SPNE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.673 0.641 -0.306
2021-03-31 0.718 0.635 -0.381
2020-12-31 0.694 0.632 -0.391
2020-09-30 0.743 0.636 -0.408
2020-06-30 0.797 0.625 -0.475
2020-03-31 0.941 0.634 -0.494

SPNE Price Target

For more insight on analysts targets of SPNE, see our SPNE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.61 Average Broker Recommendation 1.21 (Strong Buy)

SPNE Stock Price Chart Interactive Chart >

Price chart for SPNE

SPNE Price/Volume Stats

Current price $16.23 52-week high $22.97
Prev. close $15.75 52-week low $12.43
Day low $15.76 Volume 75,400
Day high $16.27 Avg. volume 156,448
50-day MA $16.82 Dividend yield N/A
200-day MA $18.49 Market Cap 590.74M

SeaSpine Holdings Corporation (SPNE) Company Bio


SeaSpine Holdings Corporation is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company was founded in 2015 and is based in in Vista, California


SPNE Latest News Stream


Event/Time News Detail
Loading, please wait...

SPNE Latest Social Stream


Loading social stream, please wait...

View Full SPNE Social Stream

Latest SPNE News From Around the Web

Below are the latest news stories about SeaSpine Holdings Corp that investors may wish to consider to help them evaluate SPNE as an investment opportunity.

SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference

CARLSBAD, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021, beginning at 8:00 am ET. A live and archived webcast of the event will be available from the Investor Relations page of the Company's website at investor.seaspine.com. About

Yahoo | September 22, 2021

SeaSpine to Host Analyst & Investor Event on September 30, 2021

CARLSBAD, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Boston, Massachusetts on Thursday, September 30 from 7:30 a.m. to 8:45 a.m. Eastern Time. The meeting will include remarks from members of the SeaSpine leadership team on the Company’s differentiated technologies and growth strateg

Yahoo | September 16, 2021

One SeaSpine Holdings Corporation (NASDAQ:SPNE) insider upped their stake by 13% in the previous year

Looking at SeaSpine Holdings Corporation's ( NASDAQ:SPNE ) insider transactions over the last year, we can see that...

Yahoo | September 10, 2021

OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications

Enables OrthoPediatrics to Further Address Full Patient Continuum of Care for Pediatric Orthopedic Surgeons with Market-Leading, Radiation-Free Navigation TechnologyWARSAW, Ind., Sept. 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced they have entered into a distribution agreement with SeaSpine® Orthopedics Corporation, a wholly-owned subsidiary of

Yahoo | September 9, 2021

SeaSpine Announces Initial Launch of Mariner Adult Deformity System

CARLSBAD, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries of the Mariner Adult Deformity Pedicle Screw System.

Intrado Digital Media | September 7, 2021

Read More 'SPNE' Stories Here

SPNE Price Returns

1-mo 2.01%
3-mo -22.49%
6-mo -10.13%
1-year 18.29%
3-year 4.71%
5-year 56.81%
YTD -6.99%
2020 45.30%
2019 -34.16%
2018 80.24%
2017 28.10%
2016 -54.02%

Continue Researching SPNE

Here are a few links from around the web to help you further your research on SeaSpine Holdings Corp's stock as an investment opportunity:

SeaSpine Holdings Corp (SPNE) Stock Price | Nasdaq
SeaSpine Holdings Corp (SPNE) Stock Quote, History and News - Yahoo Finance
SeaSpine Holdings Corp (SPNE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8575 seconds.